RecruitingNCT07363551
About this title
Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression
Read the official source — NCT07363551Official study titleOmega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression (OMIMYDep)- A Double-blind Randomized Controlled Trial
In TaichungDepression, ADHDPlacebo comparisonAges 13–18
- Countries
- Taiwan
- Sponsor
- China Medical University Hospital
Not Yet RecruitingNCT06115200
This study isn't recruiting yet.
Location not clearly listedPersonality disorders, PTSD, ...Observational studyAges 18+
- Countries
- Sponsor
- Helse Stavanger HF
CompletedNCT03785223
Official study titleA 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
This study has finished and is no longer accepting participants.
In HamiltonAnxiety, ADHDMedication studyAges 18–65
- Countries
- Canada
- Sponsor
- McMaster University
CompletedNCT02287038
Official study titleAtomoxetine in Comorbid ADHD/PTSD: A Pilot, Placebo-Controlled Feasibility Study
This study has finished and is no longer accepting participants.
In CharlestonPTSD, ADHDMedication studyAges 20–60
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)
TerminatedNCT01506232
Official study titleBrain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary Study
This study ended early.
In CambridgeBipolarity, ADHDObservational studyAges 6–17
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT00936299
Official study titleBupropion for ADHD in Adolescents With Substance Use Disorder
This study has finished and is no longer accepting participants.
In DenverAddiction, ADHDMedication studyAges 13–19
- Countries
- United States
- Sponsor
- University of Colorado, Denver
CompletedNCT05592119
Official study titleEffect of Stimulant Medication on Loss of Control Eating in Youth With Attention Deficit/Hyperactivity Disorder: a Prospective, Observational Case Series
This study has finished and is no longer accepting participants.
In HalifaxEating disordersObservational studyAges 8–13
- Countries
- Canada
- Sponsor
- Nova Scotia Health Authority
CompletedNCT04336072
Official study titleTrial of Reminder Focused Positive Psychiatry in Comorbid Attention Deficit Hyperactive Disorder With Posttraumatic Stress Disorder
This study has finished and is no longer accepting participants.
In Los AngelesPTSD, ADHDBehavioural studyAges 9–18
- Countries
- United States
- Sponsor
- University of California, Los Angeles
CompletedEUCTR 2006-002249-35
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In SwedenAddiction, ADHDHistorical research recordAges 18+
- Countries
- Sweden
- Sponsor
- Addiction Center Stockholm
CompletedNCT00316290
Official study titleIntegrated Treatment for Depressed Mothers of ADHD Children
This study has finished and is no longer accepting participants.
In College ParkDepression, ADHDBehavioural studyAges 6+
- Countries
- United States
- Sponsor
- University of Maryland, College Park
CompletedNCT06973577
Official study titleA Phase 3b, Randomized, Double-blind, 8-week, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Centanafadine Once Daily Extended-release Capsules for the Treatment of Adults With Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety
This study has finished and is no longer accepting participants.
Multiple locations, including DothanAnxiety, ADHDMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT00305370
Official study titleAripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Cross-Over Placebo Controlled Trial
This study has finished and is no longer accepting participants.
In Porto AlegreBipolarity, ADHDMedication studyAges 8–17
- Countries
- Brazil
- Sponsor
- Federal University of Rio Grande do Sul